Clinical TrialsSearch results
Number of results: 529
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Effect of Meniett device on clinical symptoms in patients with endolymphatic hydrops
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-08-31
Other
- Effect of middle ear pressure change on clincal symptoms in patients with endolymphatic hydrops of the inner ear
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-10-01
Other
- Effect of non-steroidal anti-inflammatory drugs external patch for Knee Osteoarthritis; An Open label Randomized Controlled Trial.
- Knee Osteoarthritis
- The Japanese Society for Musculoskeletal Rehabilitation
- 2005-11-15
Other
- Effectiveness of probiotics against oral mucositis
- Breast cancer
- Kawaguchi Hiroyuki
- 2021-08-03
Other
- Effects of low-intensity pulsed ultrasound (LIPUS) treatment in post-operative scaphoid delayed unions or nonunions: multi-institutional prospective randomized controlled trial
- scaphoid delayed unions and nonunions
- Japanese Society for Surgery of the Hand, Tsukuba Critical Path Research and Education Integrated Leading Center (CREIL)
- 2009-06-01
Other
- Effects of modifications of CKD care systems at general practice physicians on cooperation with nephrologists and outcome of CKD patients.
- chronic kidney disease
- University of Tsukuba
- 2008-05-16
Other
- Efficacy and safety of tolvaptan for patients with ascites after liver resection, prospective study(Efficacy and safety of tolvaptan after liver resection, prospective study)
- Liver tumor
- Ohdan Hideki
- 2023-03-31
Other
- Efficacy of latanoprost (Xalatan) ophthalmic solution stored at room temperature
- Glaucoma patients
- Hiroshima University Department of Ophthalmology and Visual Science
- 2007-05-31
Other
- Efficacy of Montelukast to prolonged cough.
- prolonged cough
- Kansai Asthma Research Network(KARN)
- 2009-08-21
Other
- Efficacy of PEG-IFN alfa-2b plus Ribabirin and HMG-CoA reductase inhibitor combination antiviral therapy ; pilot study
- Chronic hepatitis C
- Hiroshima liver study group
- 2007-05-09